Results 251 to 260 of about 3,770,580 (314)

A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real-world practice. [PDF]

open access: yesEJHaem
Messina M   +13 more
europepmc   +1 more source

Three novel Enterobacter cloacae bacteriophages for therapeutic use from Ghanaian natural waters. [PDF]

open access: yesArch Virol
Lyytinen OL   +5 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Therapeutic Use of Nicergoline

Clinical Drug Investigation, 2008
The ergot alkaloid derivative nicergoline became clinically available about 35 years ago in the 1970s. Nicergoline has a broad spectrum of action: (i) as an alpha(1)-adrenoceptor antagonist, it induces vasodilation and increases arterial blood flow; (ii) it enhances cholinergic and catecholaminergic neurotransmitter function; (iii) it inhibits platelet
Bengt Winblad   +6 more
openaire   +3 more sources

Therapeutic Use Exemptions

2017
The introduction, in 2004, of the World Anti-Doping Code and a standardized "prohibited list" of substances and methods proscribed in sport represented a consistent, international response to the escalating challenge of drug misuse in contemporary sport.
David, Gerrard, Andrew, Pipe
openaire   +2 more sources

Home - About - Disclaimer - Privacy